跳至主要内容

Pharmalego intermediates e-commerce platform launched; We have what scientific researchers are struggling to find

 1

E3 Ligase-CRBN、E3 Ligase-VHL、PROTAC linker……
Common building blocks in literature,
In reality, it's hard to find one!
Are you also searching for this?

PROTAC.webp

PROTAC Building Blocks

PharmlegoTM has developed more than 600 types of Linker and E3 ligase ligand building blocks, covering common long carbon chains, ethylene glycol long chains, spiroheterocyclic chains, CRBN, VHL, cIAP and MDM2 ligands and other chemical structures.

○E3 Ligase-CRBN＞100
○E3 Ligase-VHL＞100
○E3 Ligase-others ＞50
○PROTAC linker＞1000
*If we cannot meet your needs, we can also customize it for you.

For more: https://cn.pharmalego.com/service/protac-custom.html


2 

Sugar unit intermediates, base intermediates, delivery systems...
It is an intermediate that is obviously not difficult to synthesize.
But, it just takes a lot of time to synthesize!
Are you also doing this for 996 and 007?

Nucleic Acid Drugs.webp

Nucleic Acid Drugs

PharmalegoTM can efficiently and quickly provide customization and research and development services for monomers and delivery systems.  At present, we have more than 300 synthetic building blocks, which can modify and transform the ribose, base, and phosphate backbone of the monomers, as well as the delivery system, including the modification and transformation of GalNAc and LNP.

○Sugar modification>100 kinds of sugar unit intermediates
○Base modification>50 kinds of base intermediates
○Backbone modification, Rich experience in backbone modification chemistry
○Delivery system 1500+LNP, 30*GalNAc synthesis experience

*If we cannot meet your needs, we can also customize it for you.

For more:https://cn.pharmalego.com/service/oligonucleotides-custom.html

3
ADC linkers、Toxins、Payloads……
Even if there is an intermediate missing,
It’s like cooking without rice!
Are you also feeling helpless?

ADC.webp

ADC

PharmalegoTM has R&D laboratories and highly active drug production capabilities.  The scientific research team has professional and rich chemical modification technology and capabilities.  In-house toxins and linkers can meet customers' research and development needs from milligram to kilogram levels, and provide full-process services from drug development to preclinical CMC production.


300+ADC Linkers
50+ Toxins
30+ Payloads

Calendula: MMAE; MMAF
Maytansinoids: DM1; DM4
Pyrrobenzazepines and chlorobenzazepines: PBD
Camptothecins: DX; SD38

*If we cannot meet your needs, we can also customize it for you.

For more: https://cn.pharmalego.com/service/adc-custom.html

4
Benzene ring intermediates, pyridine intermediates, deuterated intermediates, pyrimidine intermediates...
Isn’t it time to use intermediates?
Research and development is difficult unless you have experienced it yourself!
Do you often start from scratch?

Intermediates

PharmalegoTM's pharmaceutical intermediate products cover a wide range of categories.  Including benzene ring intermediates, pyrimidine intermediates, pyridine intermediates and various heterocyclic intermediates, we provide clients with high-quality and high-purity intermediates to shorten the time to obtain target products and meet the different needs of clients.

Benzene Ring Intermediates, Aniline, Phenol, Benzaldehyde, Phenyl ether, phenylboronic acid, benzoyl, acetophenone, biphenyl...
Pyridine intermediates Aminopyridine Halopyridine Boric acid pyridine Hydroxypyridine Cyanopyridine Acylpyridine...
Deuterated Intermediates, Deuterated Anisole
Pyrimidine Intermediates, Aminopyrimidine, Arylamine Pyrimidine, Arylpyrimidine, Arylhydroxypyrimidine, Halopyrimidine, Hydroxypyrimidine...
Heterocyclic Intermediates, Benzopyrroles, Benzopyrans, Benzopyrazoles, Benzoxazines, Benzoxazoles...
Other, NA, Amino Acids, Naphthenes, Kinase Inhibitor, Spiro Ring, Bridge Ring, Alkynes, Alkylamine, Alkyl Acid, Alkenes...
*If we cannot meet your needs, we can also customize it for you.

For more:https://cn.pharmalego.com/service/intermediates-synthesis.html

5
High-End = Noble = High Price?
Are customized intermediates out of reach?
Fight for price, but also fight for quality?
Fight for purity, but also fight for safety?
Fight for buying, but also fight for customization?
Fight for after sales, but also fight for logistics?
Fight for research, but also fight for consultation?

PharmalegoTM Intermediate E-commerce Platform

Collection of synthetic biology technology service platform, analysis technology service platform, salt form and crystal form technology service platform, PROTAC R&D service platform, siRNA/ASO synthesis technology, ADC R&D service platform, electrochemistry technology service platform, photochemical technology service platform, continuous flow process technology service platform and other service platforms, Medicilon committed to cutting-edge, efficient, green and sustainable synthesis, from high-end intermediates to unique customization, and the entire process supports the research and development of new drugs.

Easy to Use, multiple compound search methods, logistics information can be traced
Multiple Guarantees, QA/QC quality control, guaranteed quality and guaranteed after-sales service
People-Oriented, multiple online consultation and feedback service channels
Flexible Form, online order purchasing, customization and synthesis
https://cn.pharmalego.com/
Everything you want is available here →

The birth of every new drug embodies the hard work and wisdom of countless scientific researchers.

From a one-stop biopharmaceutical preclinical R&D service platform, to Medicilon Academician Innovative Drug Maturation Center and New Drug Ecological Assistance Platform, to building a pharmaceutical network (PharmalegoTM), Medicilon is willing to help you overcome the obstacles on the journey of new drug research and development.  Medicilon let you forge ahead on the road of research and development, ride the wind and waves, and bravely climb to the pinnacle of innovation!

标签：

评论

发表评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...
发表评论
阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...
发表评论
阅读全文

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...
发表评论
阅读全文